CASTLEBAR_HEALTHCARE_LIMI - Accounts


Company registration number 02693448 (England and Wales)
CASTLEBAR HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
CASTLEBAR HEALTHCARE LIMITED
COMPANY INFORMATION
Director
Mr Osman Ertosun
Company number
02693448
Registered office
Kalamu House
11 Coldbath Square
London
EC1R 5HL
Auditor
KLSA LLP
Kalamu House
11 Coldbath Square
London
EC1R 5HL
Bankers
Barclays Bank Plc
50 Pall Mall
PO Box 15162
London
SW1A 1QB
CASTLEBAR HEALTHCARE LIMITED
CONTENTS
Page
Director's report
1
Director's responsibilities statement
2
Independent auditor's report
3 - 6
Profit and loss account
7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 18
CASTLEBAR HEALTHCARE LIMITED
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 MARCH 2023
- 1 -

The director presents his annual report and financial statements for the year ended 31 March 2023.

Principal activities

The principal activity of the company was that of the operation of a care home for the elderly until 4 May 2021 when the company ceased trading; the company is not trading currently.

Results and dividends

The results for the year are set out on page 7.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Mr Osman Ertosun
Auditor

The auditor, KLSA LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr Osman Ertosun
Director
18 December 2023
CASTLEBAR HEALTHCARE LIMITED
DIRECTOR'S RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2023
- 2 -

The director is responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

CASTLEBAR HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CASTLEBAR HEALTHCARE LIMITED
- 3 -
Opinion

We have audited the financial statements of Castlebar Healthcare Limited (the 'company') for the year ended 31 March 2023 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

 

  •     give a true and fair view of the state of the company's affairs as at 31 March 2023 and of its loss for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Emphasis of matter - Financial statements prepared on a basis other than going concern

We draw attention to note 1.1 to the financial statements which explains that the company ceased trading as a care home. Therefore, the director does not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly, the financial statements have been prepared on a basis other than going concern as described in Note 1.1. Our opinion is not modified in respect of this matter.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The director is responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

 

  • the information given in the director's report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the director's report has been prepared in accordance with applicable legal requirements.

CASTLEBAR HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CASTLEBAR HEALTHCARE LIMITED
- 4 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the director's report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit.

Responsibilities of director

As explained more fully in the director's responsibilities statement, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Extent to which the audit was considered capable of detecting irregularities, including fraud and non-compliance with laws and regulations

To identify risks of material misstatement due to any irregularities, including fraud and non-compliance with laws and regulations, we assessed events or conditions that could indicate an incentive or pressure to commit fraud or provide an opportunity to commit fraud. Our risk assessment procedures included:

 

  • the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;

  • we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the sector; and

  • we focused on specific laws and regulations which we considered may have a direct material effect on the operations of the company, financial statements including the Companies Act 2006, taxation legislation and data protection, employment, health and safety legislation and Care Quality Commission (Registration) Regulations 2009.

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

 

  • making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and

  • considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

CASTLEBAR HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CASTLEBAR HEALTHCARE LIMITED
- 5 -

To address the risk of fraud through management bias and override of controls, we:

 

  • performed analytical procedures to identify any unusual or unexpected relationships;

  • tested journal entries to identify unusual transactions;

  • assessed whether judgements and assumptions made in determining the accounting estimates set out in note 2 were indicative of potential bias;

  • investigated the rationale behind significant or unusual transactions;

  • reviewed the financial statements disclosures and determining whether accounting policies have been appropriately applied;

  • obtaining third-party confirmation of material bank balances; and

  • documenting and verifying all significant related party balances and transactions.

To address the risk of non-compliance with laws and regulations, we communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit. The potential effect of these laws and regulations on the financial statements varies considerably.

 

Firstly, the company is subject to laws and regulations that directly affect the financial statements including financial reporting legislation (including related companies legislation) and taxation legislation (including payroll taxes) and we assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statements items.

 

Secondly, the Company is subject to many other laws and regulations where the consequences of non-compliance could have a material effect on amounts or disclosures in the financial statements, for instance through the imposition of fines or litigation or the loss of the Company’s license to operate. We identified the following areas as those most likely to have such an effect: Care Quality Commission’s Inspections and healthcare and safety legislation regulations. Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the Directors and other management and inspection of regulatory and legal correspondence, if any. Therefore, if a breach of operational regulations is not disclosed to us or evident from relevant correspondence, an audit will not detect that breach.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards; for instance, any non-compliance with laws and regulations and fraud which is far removed from transactions reflected in the financial statements would diminish the likelihood of detection. Furthermore, the risk of not detecting a material misstatement due to fraud is greater than the risk of not detecting one resulting from error.

 

Fraud may involve deliberate concealment by, for example, forgery or intentional omissions, misrepresentation, or through an act of collusion that would mitigate internal controls. Our audit procedures are designed to detect material misstatement. We are not responsible for preventing non-compliance or fraud and cannot be expected to detect non-compliance with all laws and regulations.

 

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

CASTLEBAR HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CASTLEBAR HEALTHCARE LIMITED
- 6 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Shilpa Chheda (Senior Statutory Auditor)
For and on behalf of KLSA LLP
18 December 2023
Chartered Accountants
Statutory Auditor
Kalamu House
11 Coldbath Square
London
EC1R 5HL
CASTLEBAR HEALTHCARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2023
- 7 -
2023
2022
Notes
£
£
Turnover
2
-
104,944
Cost of sales
-
0
(161,353)
Gross profit/(loss)
-
(56,409)
Distribution costs
(663)
(2,462)
Administrative expenses
(43,024)
57,205
Other operating income
4,654
3,693
Exceptional item
3
(3,800,090)
(955)
(Loss)/profit before taxation
(3,839,123)
1,072
Tax on (loss)/profit
6
-
0
-
0
(Loss)/profit for the financial year
(3,839,123)
1,072
CASTLEBAR HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2023
- 8 -
2023
2022
£
£
(Loss)/profit for the year
(3,839,123)
1,072
Other comprehensive income
-
-
Total comprehensive income for the year
(3,839,123)
1,072
CASTLEBAR HEALTHCARE LIMITED
BALANCE SHEET
AS AT 31 MARCH 2023
31 March 2023
- 9 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
7
250,240
9,954,985
Cash at bank and in hand
186,323
1,089,421
436,563
11,044,406
Creditors: amounts falling due within one year
8
(170,486)
(6,939,206)
Net current assets
266,077
4,105,200
Capital and reserves
Called up share capital
10
10,000
10,000
Profit and loss reserves
256,077
4,095,200
Total equity
266,077
4,105,200

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 18 December 2023
Mr Osman Ertosun
Director
Company Registration No. 02693448
CASTLEBAR HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2023
- 10 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 April 2021
10,000
4,094,128
4,104,128
Year ended 31 March 2022:
Profit and total comprehensive income
-
1,072
1,072
Balance at 31 March 2022
10,000
4,095,200
4,105,200
Year ended 31 March 2023:
Loss and total comprehensive income
-
(3,839,123)
(3,839,123)
Balance at 31 March 2023
10,000
256,077
266,077
CASTLEBAR HEALTHCARE LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2023
- 11 -
2023
2022
Notes
£
£
£
£
Cash flows from operating activities
Cash absorbed by operations
13
(903,098)
(371,849)
Investing activities
Proceeds from disposal of tangible fixed assets
-
0
(74,873)
Proceeds from disposal of investments
-
0
436,416
Net cash (used in)/generated from investing activities
-
361,543
Net decrease in cash and cash equivalents
(903,098)
(10,306)
Cash and cash equivalents at beginning of year
1,089,421
1,099,727
Cash and cash equivalents at end of year
186,323
1,089,421
CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 12 -
1
Accounting policies
Company information

Castlebar Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kalamu House, 11 Coldbath Square, London, EC1R 5HL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

 

The financial statements have been prepared on a basis other than going concern based on the fact that the company ceased trading as disclosed in the Director's Report. This basis includes:

 

  •     All assets are valued at the lower of cost and net realisable value;

  •     Any other material costs associated with winding up the business are recognised.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents fees receivable for care services. Turnover is recognised as it is incurred, either daily, weekly or monthly. Where charges are billed in advance these are recorded as deferred income.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 13 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

1.6
Retirement benefits
1.7
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.8

Comparatives

There were no changes in presentation in the current year.

2
Turnover and other revenue
2023
2022
£
£
Turnover analysed by class of business
Care Home Services
-
104,944
2023
2022
£
£
Other revenue
Grants received
-
3,692
3
Exceptional item
2023
2022
£
£
Expenditure
Inter - group loan balances written off
3,800,090
955
CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 14 -
4
Operating (loss)/profit
2023
2022
Operating (loss)/profit for the year is stated after charging/(crediting):
£
£
Government grants
-
(3,692)
(Profit)/loss on disposal of tangible fixed assets
-
74,873
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Care Staff
-
9
Director
-
1
Total
-
0
10

Their aggregate remuneration comprised:

2023
2022
£
£
Wages and salaries
39,837
(15,167)
Pension costs
-
0
3,877
39,837
(11,290)
6
Taxation

The actual charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:

2023
2022
£
£
(Loss)/profit before taxation
(3,839,123)
1,072
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 19.00% (2022: 19.00%)
(729,433)
204
Tax effect of expenses that are not deductible in determining taxable profit
729,586
14,407
Tax effect of income not taxable in determining taxable profit
-
0
(36,953)
Unutilised tax losses carried forward
-
0
7,167
Group relief
(153)
15,175
Taxation charge for the year
-
-
CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 15 -
7
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
-
0
428
Amounts owed by group undertakings
250,000
6,003,017
Other debtors
240
3,941,350
Prepayments and accrued income
-
0
10,190
250,240
9,954,985
8
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
-
0
214
Amounts owed to group undertakings
6,048
6,717,091
Other creditors
163,048
213,561
Accruals and deferred income
1,390
8,340
170,486
6,939,206
9
Retirement benefit schemes
2023
2022
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
-
3,877
10
Share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
10,000
10,000
10,000
10,000
CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 16 -
11
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

 

The balance receivable from related parties at the year end date are as follows:

 

Abbotts Care Centre Limited - nil (2022 - £426,962)

 

Aliwal Healthcare Limited - nil (2022 - £83,597)

 

Brook Healthcare Limited - nil (2022 - 69,050)

 

Buchan Healthcare Limited - nil (2022 - £162,932)

 

Castle Mead Court Care Centre Limited - nil (2022 - £216,579)

 

Dovecote Manor Healthcare Limited - nil (2022 - £135,975)

 

Dovercourt Healthcare Limited - nil (2022 - £339,203)

 

Etheldred Healthcare Limited - nil (2022 - £223,597)

 

Excelcare Equities Limited - £250,000 (2022 - £250,000)

 

Ferrolake Limited - nil (2022 - £139,585)

 

Fitzwilliam Healthcare Limited - nil (2022 - £101,755)

 

Glenfield Healthcare Limited - nil (2022 - £215,504)

 

Hunters Healthcare Limited - nil (2022 - £216,516)

 

Latchworth Limited - nil (2022 - £500,532)

 

Neath Hill Care Centre Limited - nil (2022 - £116,142)

 

Primrose Healthcare Limited - nil (2022 - £99,201)

 

Lancewood Limited - nil (2022 - £269,919)

 

Rheola Healthcare Limited - nil (2022 - £83,733)

 

Saffron Healthcare Limited - nil (2022 - £185,389)

 

St Fillan Healthcare Limited - nil (2022 - £185,454)

 

St George's Court Healthcare Limited - nil (2022 - £187,016)

 

Excelcare Home Care Divisions Limited - nil (2022 - £256,203)

 

Water Hall Healthcare Limited - nil (2022 - £168,513)

 

Willows Care Centre Limited - nil (2022 - £290,881)

 

There were material transactions during the year with all the above companies due to Castlebar Healthcare Limited acting as the group head office until Park Avenue Healthcare Limited took over that function.

 

The nature of the transactions were mainly the re-assignment of inter group balances.

CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
11
Related party transactions
(Continued)
- 17 -

The balances payable to related parties at the year end date are as follows:

 

 

Ashlyn Healthcare Limited - nil (2022 - £35,663))

 

Excelcare (Cambridge) Limited - nil (2022 - nil)

 

Goldenley Healthcare Limited - nil (2022 - £86,153)

 

Limetree Healthcare Limited - £537 (2022 - £383,991)

 

Longfield Healthcare Limited - nil (2022 - £127,014)

 

Okeley Healthcare Limited - nil (2022 - £116,698)

 

Sherrel Healthcare Limited - nil (2022 - £467,689)

 

Springmarsh Homes Limited - nil (2022 - £132,035)

 

Sweyne Healthcare Limited - nil (2022 - £114,934)

 

Windmill Healthcare Limited - nil (2022 - £116,046)

 

Winifred Healthcare Limited - £542 (2022 - £291,365)

 

 

There were material transactions during the year with all the above companies due to Castlebar Healthcare Limited acting as the group head office until Park Avenue Healthcare Limited took over the function. Transactions mainly consisted of the re-assignment of inter group balances.

 

No guarantees have been given or received.

12
Ultimate controlling party

In the opinion of the directors, the ultimate parent company is Excel Portfolios Limited, a company registered in Jersey. The immediate parent company is Excelcare (London) Limited, a company incorporated in England & Wales. The ultimate joint controlling party is E Ertosun and O Ertosun.

The smallest undertaking for which group financial statements are prepared is Excelcare (London) Limited. The copies of these consolidated financial statements can be obtained from Kalamu House, 11 Coldbath Square, London EC1R 5HL.

The largest undertaking for which group financial statements are prepared is Excel Portfolios Limited. The copies of these consolidated financial statements can be obtained from St Paul’s Gate, Fourth Floor, 22 – 24 New Street, St Helier, Jersey JE1 4TR.

 

CASTLEBAR HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 18 -
13
Cash absorbed by operations
2023
2022
£
£
(Loss)/profit for the year after tax
(3,839,123)
1,072
Adjustments for:
(Gain)/loss on disposal of tangible fixed assets
-
74,873
Movements in working capital:
Decrease in stocks
-
0
1,900
Decrease/(increase) in debtors
9,704,745
(6,159,821)
(Decrease)/increase in creditors
(6,768,720)
5,710,127
Cash absorbed by operations
(903,098)
(371,849)
14
Analysis of changes in net funds
1 April 2022
Cash flows
31 March 2023
£
£
£
Cash at bank and in hand
1,089,421
(903,098)
186,323
2023-03-312022-04-01falseCCH SoftwareCCH Accounts Production 2023.300Mr Osman Ertosunfalse026934482022-04-012023-03-3102693448bus:Director12022-04-012023-03-3102693448bus:RegisteredOffice2022-04-012023-03-3102693448bus:Agent12022-04-012023-03-31026934482023-03-31026934482021-04-012022-03-310269344812022-04-012023-03-310269344812021-04-012022-03-3102693448core:RetainedEarningsAccumulatedLosses2021-04-012022-03-3102693448core:RetainedEarningsAccumulatedLosses2022-04-012023-03-31026934482022-03-3102693448core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3102693448core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3102693448core:CurrentFinancialInstruments2023-03-3102693448core:CurrentFinancialInstruments2022-03-3102693448core:ShareCapital2023-03-3102693448core:ShareCapital2022-03-3102693448core:RetainedEarningsAccumulatedLosses2023-03-3102693448core:RetainedEarningsAccumulatedLosses2022-03-3102693448core:ShareCapital2021-03-3102693448core:RetainedEarningsAccumulatedLosses2021-03-31026934482022-03-31026934482021-03-3102693448core:UKTax2022-04-012023-03-3102693448core:UKTax2021-04-012022-03-3102693448bus:PrivateLimitedCompanyLtd2022-04-012023-03-3102693448bus:FRS1022022-04-012023-03-3102693448bus:Audited2022-04-012023-03-3102693448bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP